Holen Sie sich die Stockscreener-App
1.34
32.67%
0.33
Handel nachbörslich:
1.36
0.02
+1.49%
Schlusskurs vom Vortag:
$1.01
Offen:
$1.195
24-Stunden-Volumen:
74.52M
Relative Volume:
37.79
Marktkapitalisierung:
$67.39M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-56.85M
KGV:
-0.8595
EPS:
-1.559
Netto-Cashflow:
-
1W Leistung:
+35.56%
1M Leistung:
+32.67%
6M Leistung:
+5.51%
1J Leistung:
-47.04%
1-Tages-Spanne:
$1.06
$1.36
1-Wochen-Bereich:
$0.96
$1.36
52-Wochen-Spanne:
$0.825
$3.481
Fractyl Health Inc Stock (GUTS) Company Profile
Firmenname
Fractyl Health Inc
Sektor
Branche
Telefon
781-902-8800
Adresse
3 VAN DE GRAAFF DRIVE, BURLINGTON
Vergleichen Sie GUTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
1.34 | 71.53M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.74 | 97.91B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.90 | 58.88B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.40 | 58.93B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
711.62 | 43.52B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
326.06 | 36.11B | 3.81B | -644.79M | -669.77M | -6.24 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-08-28 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-02-28 | Eingeleitet | Evercore ISI | Outperform |
| 2024-02-27 | Eingeleitet | BofA Securities | Buy |
| 2024-02-27 | Eingeleitet | Morgan Stanley | Overweight |
Fractyl Health Inc Aktie (GUTS) Neueste Nachrichten
Fractyl Health’s Strategic Moves Boost Investor Confidence - StocksToTrade
GUTS Stock Surges After Promising Clinical Results and Strategic Moves - timothysykes.com
Fractyl Health (GUTS) Is Up 35.6% After Revita Shows Weight Loss Maintained Post-GLP-1 and $60M Raise - Yahoo Finance
Fractyl Health stock gains after pricing of $60M underwritten offering - MSN
Fractyl Health Surges Amid Share Offering, Positive Trial Results - StocksToTrade
Fractyl Health Surges Amid Positive Trial Results and Strategic Developments - timothysykes.com
Latham & Watkins Advises on Fractyl Health’s US$60 Million Underwritten Offering of Common Stock - Latham & Watkins LLP
HC Wainwright & Co. Maintains Fractyl Health (GUTS) Buy Recommendation - Nasdaq
Fractyl Health Inc files for offering of up to 60 million shares of common stockSEC filing - MarketScreener
Fractyl Health (NASDAQ:GUTS) Price Target Lowered to $8.00 at HC Wainwright - MarketBeat
Fractyl Health (GUTS) Stock: Climbs as Company Prices $60M Underwritten Offering at $1.00/Share - parameter.io
Fractyl Health Announces $60M Stock Offering Pricing - MSN
GUTS Stock Rallied About 28% Today – Here’s Why - Stocktwits
Fractyl Health says experimental procedure helps maintain weight-loss in study - whbl.com
Fractyl's Revita shows promise in post-GLP-1 weight maintenance - The Business Journals
Fractyl Health says experimental procedure helps maintain weight loss in study - Reuters
Fractyl Health gains as experimental procedure helps maintain weight-loss in study - TradingView
Fractyl Health Stock Surge: Buying Opportunity? - StocksToTrade
Transcript : Fractyl Health, Inc.Special Call - MarketScreener
Fractyl Health’s Stock Surge: Analyzing Market Dynamics - timothysykes.com
Fractyl Health prices $60 million common stock offering at $1 per share - Investing.com India
GUTS Stock Price and Chart — NASDAQ:GUTS - TradingView
Fractyl’s Revita shows promise in preventing weight regain after GLP-1 use - Investing.com India
Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock - Nasdaq
Fractyl Health Says Trial Results Support Revita as First Therapy for Post-GLP-1 Weight Maintenance; Shares Rise Pre-Bell - MarketScreener
Fractyl Health's experimental weight-loss procedure shows promise in study - MarketScreener
Fractyl Health announces groundbreaking data from Remain-1 midpoint cohort showing Revita maintained weight loss after GLP-1 discontinuation - MarketScreener
Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita Maintained Weight Loss After GLP-1 Discontinuation - TradingView
Fractyl Health announces pricing of $60 million underwritten offering of common stock - MarketScreener
$60 Million Stock Offering: Metabolic Therapeutics Company Fractyl Health Raises Capital at $1 Per Share - Stock Titan
Fractyl Health Announces Groundbreaking Data from REMAIN-1 - GlobeNewswire
12.5% Treatment Difference: Fractyl's Revita Procedure Maintains Weight Loss After Stopping Popular GLP-1 Drugs - Stock Titan
Multi factor analysis applied to Fractyl Health Inc.Share Buyback & Fast Gain Stock Tips - newser.com
Real time breakdown of Fractyl Health Inc. stock performanceWeekly Market Report & Long Hold Capital Preservation Tips - newser.com
How to escape a deep drawdown in Fractyl Health Inc.2025 Bull vs Bear & High Accuracy Trade Signal Alerts - newser.com
How to use Fibonacci retracement on Fractyl Health Inc.Quarterly Trade Summary & Real-Time Volume Surge Alerts - newser.com
FOMO Trade: Can Fractyl Health Inc outperform under higher oil pricesGap Up & Reliable Breakout Stock Forecasts - خودرو بانک
What indicators show strength in Fractyl Health Inc.Weekly Earnings Recap & High Win Rate Trade Alerts - newser.com
Fractyl Health (NASDAQ:GUTS) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
Growth Value: Should value investors consider DAWNJuly 2025 PreEarnings & Consistent Profit Alerts - khodrobank.com
How to manage a losing position in Fractyl Health Inc.2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com
What machine learning models say about Fractyl Health Inc.Rate Cut & Risk Adjusted Buy/Sell Alerts - newser.com
Will Fractyl Health Inc. see short term momentumTrade Analysis Report & Consistent Profit Focused Trading Strategies - newser.com
Applying chart zones and confluence areas to Fractyl Health Inc.2025 Investor Takeaways & Real-Time Sentiment Analysis - newser.com
What technical models suggest about Fractyl Health Inc.’s comebackJuly 2025 Gainers & Technical Entry and Exit Tips - newser.com
Aug Breakouts: Should I add Fractyl Health Inc stock to my portfolioTrade Exit Summary & Technical Entry and Exit Tips - خودرو بانک
Fractyl Health Appoints New Directors Amid Leadership Changes - MSN
Aug Macro: Is Fractyl Health Inc undervalued by DCF analysisJuly 2025 Volume & Weekly Return Optimization Plans - خودرو بانک
Has Fractyl Health Inc. formed a bullish divergence2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com
FOMO Trade: Can Fractyl Health Inc. expand into new marketsWeekly Loss Report & Daily Technical Stock Forecast Reports - خودرو بانک
Insider Sell: Is Fractyl Health Inc in a long term uptrendMarket Growth Summary & Real-Time Stock Movement Alerts - خودرو بانک
Finanzdaten der Fractyl Health Inc-Aktie (GUTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Fractyl Health Inc-Aktie (GUTS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Barnes Kelly Ann | Director |
Mar 14 '25 |
Buy |
1.30 |
31,000 |
40,210 |
31,000 |
| SCHULMAN AMY W | Director |
Mar 13 '25 |
Buy |
1.17 |
8,550 |
9,964 |
8,550 |
| BRADLEY WILLIAM | Director |
Mar 13 '25 |
Buy |
1.26 |
16,129 |
20,358 |
16,129 |
| Conaway Samuel | Director |
Mar 13 '25 |
Buy |
1.17 |
8,550 |
9,964 |
8,550 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 31 '25 |
Option Exercise |
1.70 |
90,972 |
154,652 |
582,301 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Option Exercise |
1.70 |
20,948 |
35,612 |
512,277 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 31 '25 |
Sale |
1.82 |
90,972 |
165,205 |
491,329 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Sale |
1.95 |
20,948 |
40,798 |
491,329 |
| Caplan Jay David | President, Chief Product Off. |
Jan 31 '25 |
Option Exercise |
1.70 |
22,346 |
37,988 |
175,890 |
| Caplan Jay David | President, Chief Product Off. |
Jan 30 '25 |
Option Exercise |
1.70 |
21,472 |
36,502 |
175,016 |
3.41%
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):